Glycyrrhizin inactivates toll-like receptor (TLR) signaling pathway to reduce lipopolysaccharide-induced acute lung injury by inhibiting TLR2

scientific article published on 10 September 2018

Glycyrrhizin inactivates toll-like receptor (TLR) signaling pathway to reduce lipopolysaccharide-induced acute lung injury by inhibiting TLR2 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JCP.27242
P698PubMed publication ID30203548

P50authorZanfeng WangQ91377910
P2093author name stringHui Zhou
Jie Tian
Tingwei Liu
Delei Kong
P433issue4
P921main subjectlipopolysaccharideQ421804
acute lung injuryQ4677935
P304page(s)4597-4607
P577publication date2018-09-10
P1433published inJournal of Cellular PhysiologyQ1524270
P1476titleGlycyrrhizin inactivates toll-like receptor (TLR) signaling pathway to reduce lipopolysaccharide-induced acute lung injury by inhibiting TLR2
P478volume234

Reverse relations

cites work (P2860)
Q92619215Effects of glycyrrhizin on lipopolysaccharide-induced acute lung injury in a mouse model
Q96768625Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?

Search more.